Protumorigenic role of Timeless in hepatocellular carcinoma

International Journal of Oncology

Volumn 46, Issue 2, 2015, Pages 597-606

  Elgohary, Nahla ^a,b   Pellegrino, Rossella ^a   Neumann, Olaf ^a   Elzawahry, Heba M ^b   Saber, Magdy M ^b   Zeeneldin, Ahmed A ^b   Geffers, Robert ^c   Ehemann, Volker ^a   Schemmer, Peter ^a   Schirmacher, Peter ^a   Longerich, Thomas ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b CAIRO UNIVERSITY   (Egypt)

^c HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

Circadian clock genes; Hepatocellular carcinoma; Oncogene

Indexed keywords

CHECKPOINT KINASE 2; ELONGATION FACTOR; EUKARYOTIC ELONGATION FACTOR 1A2; MESSENGER RNA; PROTEIN TIMELESS; RIBOSOME PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; CHEK2 PROTEIN, HUMAN; EEF1A2 PROTEIN, HUMAN; ELONGATION FACTOR 1; SIGNAL PEPTIDE; TIMELESS PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CELL; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; UPREGULATION; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CARCINOGENESIS; GENE EXPRESSION REGULATION; GENETICS; LIVER TUMOR; MIDDLE AGED; PATHOLOGY;

ADOLESCENT; ADULT; AGED; CARCINOGENESIS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE PROTEINS; CHECKPOINT KINASE 2; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PEPTIDE ELONGATION FACTOR 1; RNA, SMALL INTERFERING;

EID: 84918563587     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2751     Document Type: Article

References (38)

1. Reppert SM and Weaver DR: Coordination of circadian timing in mammals. Nature 418: 935-941, 2002.
2. Ko CH and Takahashi JS: Molecular components of the mammalian circadian clock. Hum Mol Genet 15 Spec No 2: R271-R277, 2006.
3. C eriani MF, Darlington TK, Staknis D, et al: Light-dependent sequestration of TIMELESS by CRYPTOCH ROME . Science 285: 553-556, 1999.
4. Benna C, Scannapieco P, Piccin A, et al: A second timeless gene in Drosophila shares greater sequence similarity with mammalian tim. Curr Biol 10: R512-R513, 2000.
5. Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F and Okamura H: Control mechanism of the circadian clock for timing of cell division in vivo. Science 302: 255-259, 2003.
6. Unsal-Kacmaz K, Mullen TE, Kaufmann WK and Sancar A: Coupling of human circadian and cell cycles by the timeless protein. Mol Cell Biol 25: 3109-3116, 2005.
7. Unsal-Kacmaz K, Chastain PD, Qu PP, et al: The human Tim/Tipin complex coordinates an Intra-S checkpoint response to UV that slows replication fork displacement. Mol Cell Biol 27: 3131-3142, 2007.
8. Yang X, Wood PA and Hrushesky WJ: Mammalian TIMELESS is required for ATM -dependent CH K2 activation and G2/M checkpoint control. J Biol Chem 285: 3030-3034, 2010.
9. B arnes JW, Tischkau SA, Barnes JA, et al: Requirement of mammalian Timeless for circadian rhythmicity. Science 302: 439-442, 2003.
10. Gotter AL, Manganaro T, Weaver DR, et al: A time-less function for mouse timeless. Nat Neurosci 3: 755-756, 2000.
11. Wood LD, Parsons DW, Jones S, et al: The genomic landscapes of human breast and colorectal cancers. Science 318: 1108-1113, 2007.
12. Fu L, Pelicano H, Liu J, Huang P and Lee C: The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 111: 41-50, 2002.
13. Fu A, Leaderer D, Zheng T, Hoffman AE , Stevens RG and Zhu Y: Genetic and epigenetic associations of circadian gene TIMELESS and breast cancer risk. Mol Carcinog 51: 923-929, 2012.
14. M azzoccoli G, Panza A, Valvano MR, et al: Clock gene expression levels and relationship with clinical and pathological features in colorectal cancer patients. Chronobiol Int 28: 841-851, 2011.
15. Neumann O, Kesselmeier M, Geffers R, et al: Methylome analysis and integrative profiling of human HCC s identify novel protumorigenic factors. Hepatology 56: 1817-1827, 2012.
16. Lee MH and Surh YJ: eEF1A2 as a putative oncogene. Ann NY Acad Sci 1171: 87-93, 2009.
17. Knudsen SM, Frydenberg J, Clark BF and Leffers H: Tissuedependent variation in the expression of elongation factor-1 alpha isoforms: isolation and characterisation of a cDNA encoding a novel variant of human elongation-factor 1 alpha. Eur J Biochem 215: 549-554, 1993.
18. L ee S, Francoeur AM , Liu S and Wang E: Tissue-specific expression in mammalian brain, heart, and muscle of S1, a member of the elongation factor-1 alpha gene family. J Biol Chem 267: 24064-24068, 1992.
19. Ruest LB, Marcotte R and Wang E: Peptide elongation factor eEF1A-2/S1 expression in cultured differentiated myotubes and its protective effect against caspase-3-mediated apoptosis. J Biol Chem 277: 5418-5425, 2002.
20. Schlaeger C, Longerich T, Schiller C, et al: Etiology-dependent molecular mechanisms in human hepatocarcinogenesis. Hepatology 47: 511-520, 2008.
21. Pellegrino R, Calvisi DF, Neumann O, et al: EEF1A2 inactivates p53 by way of PI3K/AKT/mTO R-dependent stabilization of MDM4 in hepatocellular carcinoma. Hepatology 59: 1886-1899, 2014.
22. Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45, 2001.
23. L ongerich T, Breuhahn K, Odenthal M, Petmecky K and Schirmacher P: Factors of transforming growth factor beta signalling are co-regulated in human hepatocellular carcinoma. Virchows Arch 445: 589-596, 2004.
24. Straub BK, Boda J, Kuhn C, et al: A novel cell-cell junction system: the cortex adhaerens mosaic of lens fiber cells. J Cell Sci 116: 4985-4995, 2003.
25. Smith KD, Fu MA and Brown EJ: Tim-Tipin dysfunction creates an indispensible reliance on the ATR-Chk1 pathway for continued DNA synthesis. J Cell Biol 187: 15-23, 2009.
26. M ao Y, Fu A, Leaderer D, Zheng T, Chen K and Zhu Y: Potential cancer-related role of circadian gene TIMELESS suggested by expression profiling and in vitro analyses. BMC Cancer 13: 498, 2013.
27. Lin YM, Chang JH, Yeh KT, et al: Disturbance of circadian gene expression in hepatocellular carcinoma. Mol Carcinog 47: 925-933, 2008.
28. L eman AR, Noguchi C, Lee CY and Noguchi E: Human Timeless and Tipin stabilize replication forks and facilitate sister-chromatid cohesion. J Cell Sci 123: 660-670, 2010.
29. Scaggiante B, Dapas B, Bonin S, et al: Dissecting the expression of EE F1A1/2 genes in human prostate cancer cells: the potential of EEF1A2 as a hallmark for prostate transformation and progression. Br J Cancer 106: 166-173, 2012.
30. Pinke DE and Lee JM: The lipid kinase PI4KIIIbeta and the eEF1A2 oncogene co-operate to disrupt three-dimensional in vitro acinar morphogenesis. Exp Cell Res 317: 2503-2511, 2011.
31. Pinke DE, Kalloger SE , Francetic T, Huntsman DG and Lee JM: The prognostic significance of elongation factor eEF1A2 in ovarian cancer. Gynecol Oncol 108: 561-568, 2008.
32. G ross SR and Kinzy TG : Improper organization of the actin cytoskeleton affects protein synthesis at initiation. Mol Cell Biol 27: 1974-1989, 2007.
33. G ross SR and Kinzy TG : Translation elongation factor 1A is essential for regulation of the actin cytoskeleton and cell morphology. Nat Struct Mol Biol 12: 772-778, 2005.
34. A miri A, Noei F, Jeganathan S, Kulkarni G, Pinke DE and Lee JM: eEF1A2 activates Akt and stimulates Akt-dependent actin remodeling, invasion and migration. Oncogene 26: 3027-3040, 2007.
35. Jeganathan S and Lee JM: Binding of elongation factor eEF1A2 to phosphatidylinositol 4-kinase beta stimulates lipid kinase activity and phosphatidylinositol 4-phosphate generation. J Biol Chem 282: 372-380, 2007.
36. Khacho M, Mekhail K, Pilon-Larose K, Pause A, Cote J and Lee S: eEF1A is a novel component of the mammalian nuclear protein export machinery. Mol Biol Cell 19: 5296-5308, 2008.
37. L i D, Wei T, Abbott CM and Harrich D: The unexpected roles of eukaryotic translation elongation factors in RNA virus replication and pathogenesis. Microbiol Mol Biol Rev 77: 253-266, 2013.
38. C huang SM , Chen L, Lambertson D, Anand M, Kinzy TG and Madura K: Proteasome-mediated degradation of cotranslationally damaged proteins involves translation elongation factor 1A. Mol Cell Biol 25: 403-413, 2005.